Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women

Patient Education and Counseling

Volumn 93, Issue 3, 2013, Pages 488-495

  Miller, Suzanne M ^a   Hui, Siu kuen Azor ^a   Wen, Kuang Yi ^a   Scarpato, John ^a   Zhu, Fang ^a   Buzaglo, Joanne ^b   Hernandez, Enrique E ^c  

^a FOX CHASE CANCER CENTER   (United States)

^b Cancer Support Community   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer screening; Follow up adherence; Tailored counseling

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH DISPARITY; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SOCIAL STATUS; TELECONSULTATION; UTERINE CERVIX CANCER; ATTITUDE TO HEALTH; COUNSELING; ETHNOLOGY; HEALTH CARE DISPARITY; HEALTH CARE PLANNING; MIDDLE AGED; MINORITY GROUP; POVERTY; PROCEDURES; PSYCHOLOGY; PUBLICATION; REMINDER SYSTEM; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TELEPHONE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

ADULT; COLPOSCOPY; COUNSELING; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; MINORITY GROUPS; PAMPHLETS; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PENNSYLVANIA; POVERTY AREAS; REMINDER SYSTEMS; SOCIOECONOMIC FACTORS; TELEPHONE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84888331953     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2013.08.008     Document Type: Article

References (55)

1. Center for Disease Control Cervical cancer statistics 2012, (www.cdc.gov/cancer/cervical/statistics, accessed 08.05.13).
2. National Cancer Institute Surveillance Epidemiology and End Results (SEER) stat fact sheets: cervix uteri 2013, (http://seer.cancer.gov/statfacts/html/cervix.html, accessed 14.06.13).
3. Kahn J.A., Lan D., Kahn R.S. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007, 110:87-95.
4. Center for Disease Control Center for disease control and prevention comparability of data 2000, http://www.cdc.gov/brfss/.
5. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. J Amer Med Assoc 2007, 297:813-819.
6. Hariri S., Unger E.R., Sternberg M., Dunne E.F., Swan D., Patel S., et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis 2011, 204:566-573.
7. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012, 62:147-172.
8. National Cancer Institute Fact Sheet 5.16, Pap Test 2010, (http://www.cancer.gov/cancertopics/factsheet/detection/Fs5_16.pdf, accessed 27.04.12).
9. Miller S.M., Roussi P. Cervical cancer screening. Psycho-oncology 2010, 84-89. Oxford University Press, New York. 2nd ed. J.C. Holland, W.S. Breitbart, P.B. Jacobsen, M.S. Lederberg, M.J. Loscalzo, R. McCorkle (Eds.).
10. Forhan S.E., Gottlieb S.L., Sternberg M.R., Xu F., Datta S.D., McQuillan G.M., et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics 2009, 124:1505-1512.
11. Tiltman A.J. The pathology of cervical tumours. Best Pract Res Clin Obstet Gynaecol 2005, 19:485-500.
12. Wright T.C., Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007, 11:223-239.
13. Benard V.B., Lawson H.W., Eheman C.R., Anderson C., Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 2005, 105:1323-1328.
14. Doyle J.P., Parker R.M., Jacobson T.A., McNagny S.E. Breast and cervical cancer screening in an inner-city medical walk-in clinic: taking advantage of an often missed opportunity. Am J Prev Med 1996, 12:345-350.
15. Ell K., Vourlekis B., Muderspach L., Nissly J., Padgett D., Pineda D., et al. Abnormal cervical screen follow-up among low-income Latinas: project SAFe. J Womens Health Gend Based Med 2002, 11:639-651.
16. Marcus A.C., Crane L.A., Kaplan C.P., Reading A.E., Savage E., Gunning J., et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992, 30:216-230.
17. Miller S.M., Siejak K.K., Schroeder C.M., Lerman C., Hernandez E., Helm C.W. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst 1997, 89:703-708.
18. Abercrombie P.D. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonatal Nurs 2001, 30:80-88.
19. Jean-Pierre P., Fiscella K., Freund K.M., Clark J., Darnell J., Holden A., et al. Structural and reliability analysis of a patient satisfaction with cancer-related care measure. Cancer 2011, 117:854-861.
20. National Cancer Institute Surveillance, Epidemiology and End Results 2003, (http://www.seer.cancer.gov/, accessed 15.10.03).
21. Miller S.M., Shoda Y., Hurley K. Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996, 119:70-94.
22. Lerman C., Hanjani P., Caputo C., Miller S., Delmoor E., Nolte S., et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992, 10:330-333.
23. Miller S.M., Mischel W., O'Leary, Mills M. From human papillomavirus (HPV) to cervical cancer: psychological processes in infection, detection, and control. Ann Behav Med 1996, 18:219-228.
24. Eggleston K.S., Coker A.L., Das I.P., Cordray S.T., Luchok K.J. Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt) 2007, 16:311-330.
25. Schoenberg N., Baltisberger J., Bardach S., Dignan M. Perspectives on Pap test follow-up care among rural Appalachian women. Women Health 2010, 50:580-597.
26. Elit L., Krzyzanowska M., Saskin R., Barbera L., Razzaq A., Lofters A., et al. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results. Can Fam Physician 2012, 58:e22-e31.
27. Chase D.M., Osann K., Sepina N., Wenzel L., Tewari K.S. The challenge of follow-up in a low-income colposcopy clinic: characteristics associated with noncompliance in high-risk populations. J Low Genit Tract Dis 2012, 16:345-351.
28. McBride C.M., Rimer B.K. Using the telephone to improve health behavior and health service delivery. Patient Educ Couns 1999, 37:3-18.
29. Campbell M.K., Bernhardt J.M., Waldmiller M., Jackson B., Potenziani D., Weathers B., et al. Varying the message source in computer-tailored nutrition education. Patient Educ Couns 1999, 36:157-169.
30. Marcus A.C., Crane L.A. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med 1998, 27:13-31.
31. Institute Institute of medicine committee on communication for behavior change in the 21st century: improving the health of diverse populations. Speaking of health: assessing health communication strategies for diverse populations 2002, National Academies Press, Washington, DC.
32. Miller S.M., Roussi P., Altman D., Helm W., Steinberg A. Effects of coping style on psychological reactions of low-income, minority women to colposcopy. J Reprod Med 1994, 39:711-718.
33. Center for Disease Control Sexually transmitted disease surveillance 2010 2010, 45.
34. Marcus A.C., Kaplan C.P., Crane L.A., Berek J.S., Bernstein G., Gunning J.E., et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 1998, 36:397-410.
35. Paskett E.D., Carter W.B., Chu J., White E. Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model. Med Care 1990, 28:643-656.
36. Paskett E.D., Phillips K.C., Miller M.E. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995, 86:353-359.
37. Stewart D.E., Buchegger P.M., Lickrish G.M., Sierra S. The effect of educational brochures on follow-up compliance in women with abnormal Papanicolaou smears. Obstet Gynecol 1994, 83:583-585.
38. Jeong S.J., Saroha E., Knight J., Roofe M., Jolly P.E. Determinants of adequate follow-up of an abnormal Papanicolaou result among Jamaican women in Portland, Jamaica. Cancer Epidemiol 2011, 35:211-216.
39. Bertram C.C., Magnussen L. Informational needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 2008, 20:455-462.
40. Miller S.M., Rodoletz M., Buzaglo J., Gray T., Sherman K. Monitoring attentional style among low-income minority women at risk for cervical cancer: cognitive social determinants of adjustment and adherence. 12th Annual Conference of the Society of Behavioral Medicine 2001.
41. Hui S.A., Miller S.M., Wen K.Y. Psycho-social barriers to follow-up adherence after an abnormal Pap smear result among low-income minority women. Ann Behav Med 2013, 45:s200.
42. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 2003, 102:417-427.
43. Wright T.C., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. J Amer Med Assoc 2002, 287:2120-2129.
44. Liang K.Y., Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
45. Kanfer F.H., Schefft B.K. Guiding the process of therapeutic change 1988, Research Press, Champaign, IL.
46. Bogg T., Roberts B.W. Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychol Bull 2004, 130:887.
47. Roberts B.W., Walton K.E., Bogg T. Conscientiousness and health across the life course. Rev Gen Psychol 2005, 9:156.
48. Institute Institute of medicine committee on health literacy board on neuroscience and behavioral health. Health literacy: a prescription to end confusion 2004, National Academies Press, Washington, DC.
49. Paskett E.D., Reeves K.W., McLaughlin J.M., Katz M.L., McAlearney A.S., Ruffin M.T., et al. Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials 2008, 29:847-861.
50. Fitzgibbon M.L., Prewitt T.E., Blackman L.R., Simon P., Luke A., Keys L.C., et al. Quantitative assessment of recruitment efforts for prevention trials in two diverse black populations. Prev Med 1998, 27:838-845.
51. Morse E.V., Simon P.M., Besch C.L., Walker J. Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res 1995, 8:8-14.
52. Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policymakers 2008, 103-113. American Psychological Association, Washington, DC. R.T. Croyle, J.H. Rowland (Eds.).
53. Wells K.J., Battaglia T.A., Dudley D.J., Garcia R., Greene A., Calhoun E., et al. Patient navigation: state of the art or is it science?. Cancer 2008, 113:1999-2010.
54. Freund K.M., Battaglia T.A., Calhoun E., Dudley D.J., Fiscella K., Paskett E., et al. National cancer institute patient navigation research program: methods, protocol, and measures. Cancer 2008, 113:3391-3399.
55. Paskett E.D., Harrop J., Wells K.J. Patient navigation: an update on the state of the science. CA: A Cancer J Clin 2011, 61:237-249.